首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1608743

TCV 疫苗市場：依疫苗品牌、通路、地區分類

TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

出版日期: 2024年11月15日 | 出版商:

Coherent Market Insights | 英文 167 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

TCV 疫苗市場預計 2024 年為 4.128 億美元，預計 2031 年將達到 9.359 億美元，2024 年至 2031 年複合年成長率為 12.4%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	4.128 億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	12.40%	2031年價值預測	9.359 億

圖：2024 年按地區分類的 TCV 疫苗市場佔有率（%）

近年來，由於疾病和感染疾病發生率的增加，TCV 疫苗市場穩步成長。 TCV 疫苗針對的是破傷風、白喉和百日咳，這些都是高度傳染性的細菌性呼吸道疾病。百日咳對嬰幼兒尤其危險，使其成為全球疫苗接種計畫的關鍵驅動力。儘管世界各地破傷風和白喉疫苗接種率很高，但百日咳仍繼續在學校和社區傳播，需要常規疫苗接種。人們對疫苗接種益處的認知不斷提高，以及政府為加強開發中國家的常規免疫計畫所做的努力，正在推動市場收益的成長。最近的新產品核可和評估擴大適應症的大規模臨床試驗進一步擴大了該市場的成長機會。

市場動態：

由於新興市場需求的增加和全球免疫計劃的擴大，TCV 疫苗市場預計將繼續穩定成長。推動市場的關鍵因素包括家長意識的提高、國際衛生組織擴大提出保護弱勢群體的建議，以及低收入和中等收入國家的政府補貼和資金。然而，聯合疫苗的研發、製造和分銷相關的高成本對疫苗的使用構成了重大挑戰。此外，由於錯誤訊息和宗教信仰而對疫苗猶豫不決正在阻礙一些國家的市場潛力。

本研究的主要特點

本報告對全球TCV疫苗市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

全球 TCV 疫苗市場的主要企業概況根據公司亮點、產品系列、主要亮點、績效和策略等參數列出。

主要企業包括 GSK plc.、賽諾菲、Bharat Biotech、BioFarma、Zydus Group、Emergent BioSolutions Inc.、Bavarian Nordic Inc.、Crucell Switzerland LTD.、PaxVax, Inc. 和 BIO-MED。

本報告中的見解將幫助負責人和公司經營團隊就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

TCV 疫苗全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

相關人員可以透過用於分析全球 TCV 疫苗市場的各種策略矩陣來促進決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	412.8 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	12.40%	2031 Value Projection:	935.9 Mn

The TCV vaccines market has been witnessing steady growth over the past few years due to increasing incidence of diseases and infections. TCV vaccines target tetanus, diphtheria, and pertussis/whooping cough which are highly infectious bacterial respiratory diseases. Pertussis is especially dangerous for infants and young children which has been a key factor driving vaccination programs globally. While tetanus and diphtheria vaccination rates are high worldwide, pertussis continues to spread in schools and communities necessitating regular booster doses. Growing awareness about benefits of immunization and government efforts to strengthen routine immunization programs in developing countries have boosted market revenues. Recent new product approvals and large clinical trials evaluating expansion of indication have further widened growth opportunities in this market.

Market Dynamics:

TCV vaccines market is expected to witness robust growth going forward on account of rising demand from developing regions and increasing coverage of vaccination programs worldwide. The key drivers fueling the market include growing awareness among parents, expanding recommendation by international health organizations to protect vulnerable population groups, and government subsidies and funding in low and middle income nations. However, high costs associated with R&D, manufacturing, and distribution of combination vaccines pose a major challenge to adoption rates. In addition, ongoing vaccine hesitancy due to misinformation and religious beliefs inhibits market potential in some countries.

Key Features of the Study:

This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global TCV vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GSK plc., Sanofi, Bharat Biotech, BioFarma, Zydus Group, Emergent BioSolutions Inc., Bavarian Nordic Inc., Crucell Switzerland LTD., PaxVax, Inc., and BIO-MED

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market

Market Segmentation

By Vaccine Brand Insights (Revenue, USD Mn, 2019 - 2031)
- Ty21a (Vivotif)
- ViCPS (Typhim Vi)
- Vi-TT (Peda-typhTM)
- Typbar TCV
By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Public
- UNICEF
- Tender (Govt.)
- Private
Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GSK plc.
- Sanofi
- Bharat Biotech
- BioFarma
- Zydus Group
- Emergent BioSolutions Inc.
- Bavarian Nordic Inc.
- Crucell Switzerland LTD.
- PaxVax, Inc.
- BIO-MED

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- TCV Vaccines Market, By Vaccine Brand
- TCV Vaccines Market, By Distribution Channel
- TCV Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Market Trends
Epidemiology

4. Global TCV Vaccines Market, By Vaccine Brand, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Ty21a (Vivotif)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
ViCPS (Typhim Vi)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vi-TT (Peda-typhTM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Typbar TCV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global TCV Vaccines Market, By Distribution Channel, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
UNICEF
Tender (Govt.)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global TCV Vaccines Market, By Region, 2019 - 2031, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioFarma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zydus Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emergent BioSolutions Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bavarian Nordic Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Crucell Switzerland LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PaxVax, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BIO-MED
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies